82_FR_41434 82 FR 41267 - Agency Forms Undergoing Paperwork Reduction Act Review

82 FR 41267 - Agency Forms Undergoing Paperwork Reduction Act Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 167 (August 30, 2017)

Page Range41267-41268
FR Document2017-18407

Federal Register, Volume 82 Issue 167 (Wednesday, August 30, 2017)
[Federal Register Volume 82, Number 167 (Wednesday, August 30, 2017)]
[Notices]
[Pages 41267-41268]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-18407]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-17-0004]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    National Disease Surveillance Program II. Disease Summaries (OMB 
Control Number 0920-0004, Expires 10/31/2017)--Revision--National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    CDC requests a three-year approval for the proposed revision of the 
``National Disease Surveillance Program II. Disease Summaries'' 
information collection project.
    As with the previous approval, these data are essential for 
measuring trends in diseases, evaluating the effectiveness of current 
preventive strategies, and determining the need to modify current 
preventive measures.

[[Page 41268]]

    Diseases included in this surveillance program are Influenza Virus, 
Caliciviruses, Respiratory and Enteric Viruses, Foodborne Outbreaks, 
Waterborne Outbreaks and Enteroviruses.
    Proposed revisions include form consolidation, minor revised 
language and rewording to improve clarity and readability of the data 
collection forms and the discontinuation of multiple previously 
approved influenza collection instruments, and the National Respiratory 
& Enteric Virus Surveillance System (NREVSS) Laboratory Assessment (CDC 
55.83). CDC also requests the use of a new form, Suspect Respiratory 
Virus Patient Form, to assist health departments and clinical sites 
when they submit specimens to the CDC lab for viral pathogen 
identification. The data will enable rapid detection and 
characterization of outbreaks of known pathogens, as well as potential 
newly emerging viral pathogens.
    The frequency of response for each form will depend on the disease 
and surveillance need. This represents a 7,116 burden hour reduction 
since last approval. This reduction in burden hours is attributed 
primarily to the discontinuation of previously approved forms and 
formatting changes to existing forms. The total time burden estimate 
for all collection instruments in this revision request is 24,805.
    There are no costs to the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of      Avg. burden
          Type of respondent                   Form name             Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologist.......................  NORS Foodborne Disease                 54              37           20/60
                                        Transmission_Person to
                                        Person Disease
                                        Transmission_Animal
                                        Contact_Environmental
                                        Contamination_Unknown
                                        Transmission Mode_52.13.
Epidemiologist.......................  WHO COLLABORATING CENTER               53              52           10/60
                                        FOR INFLUENZA Influenza
                                        Virus Surveillance.
Epidemiologist.......................  U.S. WHO Collaborating                113               1           10/60
                                        Laboratories Influenza
                                        Testing Methods
                                        Assessment.
Epidemiologist.......................  US Outpatient Influenza-            1,800              52           10/60
                                        like Illness
                                        Surveillance Network
                                        (ILINet) Weekly_CDC
                                        55.20.
Epidemiologist.......................  US Outpatient Influenza-             1800               1            5/60
                                        like Illness
                                        Surveillance Network
                                        (ILINet) Workfolder
                                        55.20E.
Epidemiologist.......................  Influenza-Associated                   57               2           30/60
                                        Pediatric Mortality Case
                                        Report Form.
Epidemiologist.......................  Human Infection with                   57               2           30/60
                                        Novel Influenza A Virus
                                        Case Report Form.
Epidemiologist.......................  Human Infection with                   57               1           90/60
                                        Novel Influenza A Virus
                                        Severe Outcomes.
Epidemiologist.......................  Novel Influenza A Virus                57               1           15/60
                                        Case Screening Form.
Epidemiologist.......................  Antiviral Resistant                    57               3           30/60
                                        Influenza Infection Case
                                        Report Form.
Epidemiologist.......................  National Respiratory &                550              52           15/60
                                        Enteric Virus
                                        Surveillance System
                                        (NREVSS) (55.83A, B, D)
                                        (electronic).
Epidemiologist.......................  National Enterovirus                   20              12           15/60
                                        Surveillance Report:
                                        (CDC 55.9) (electronic).
Epidemiologist.......................  National Adenovirus Type               13               4           15/60
                                        Reporting System (NATRS).
Epidemiologist.......................  Middle East Respiratory                57               3           25/60
                                        Syndrome (MERS) Patient
                                        Under Investigation
                                        (PUI) Short Form.
Epidemiologist.......................  Viral Gastroenteritis                  20               5            5/60
                                        Outbreak Submission Form.
Epidemiologist.......................  NORS Waterborne Disease                59               1           20/60
                                        Transmission Form_52.12.
Epidemiologist.......................  Influenza Virus                        57              52            5/60
                                        (Electronic, Year
                                        Round), PHLIP_HL7
                                        messaging Data Elements.
Epidemiologist.......................  Influenza virus                         3              52            5/60
                                        (electronic, year round)
                                        (PHIN-MS).
Epidemiologist.......................  Suspect Respiratory Virus              10               5           30/60
                                        Patient Form.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-18407 Filed 8-29-17; 8:45 am]
 BILLING CODE 4163-18-P



                                                                                   Federal Register / Vol. 82, No. 167 / Wednesday, August 30, 2017 / Notices                                                                                                  41267

                                                  questionnaires and provide samples for                                  ultrasounds, their head circumference                                         performed to exam developmental
                                                  laboratory testing.                                                     measured, and hearing and vision tests.                                       delays.
                                                    Researchers will follow all study-                                    For mothers and their infants,                                                   Researchers will use the study results
                                                  participating mothers’ newborns every                                   researchers will abstract relevant                                            use to guide recommendations made by
                                                  other week from birth to 6 months of                                    clinical care information from medical
                                                  age. At all visits, infants will receive                                                                                                              both INS and CDC to prevent ZIKV
                                                                                                                          records.
                                                  national recommended clinical care (at                                     The revised information collection                                         infection; to improve counseling of
                                                  birth and follow-up visits at 1, 2, and 6                               package includes the following changes.                                       patients about risks to themselves, their
                                                  months), provide samples for laboratory                                 During the data collection period,                                            pregnancies, their partners, and their
                                                  testing, and mothers will complete                                      researchers will follow a subset of 300                                       infants; and to help agencies prepare to
                                                  study-specific questionnaires about                                     infants until 2-years of age. These                                           provide services to affected children
                                                  infant ZIKV symptoms and                                                infants will have answer questionnaires                                       and families. Participation in this study
                                                  developmental milestones. During                                        at 6, 12, 18, and 24 months, as well as                                       is voluntary and there are no costs to
                                                  follow-up, infants will also have cranial                               have other clinical assessments                                               participants other than their time.

                                                                                                                         ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                                                    Average
                                                                                                                                                                                                      Number of
                                                                                                                                                                           Number of                                              burden per              Total burden
                                                            Respondents                                                  Form name                                                                  responses per
                                                                                                                                                                          respondents                                              response                  hours
                                                                                                                                                                                                      respondent                   (in hours)

                                                  Pregnant women ...................           Pregnant women eligibility questionnaire ....                                            3,125                            1                     5/60                260
                                                                                               Pregnant women enrollment questionnaire                                                  2,500                            1                    35/60              1,458
                                                                                               Adult symptoms questionnaire .....................                                       2,500                           15                    10/60              6,250
                                                                                               Pregnant women follow-up questionnaire ....                                              2,500                            8                    15/60              5,000
                                                                                               Infant symptoms questionnaire ....................                                       2,250                           14                    10/60              5,250
                                                                                               Ages and Stages Questionnaire: 2, 4, 6                                                   2,250                            2                    15/60              1,125
                                                                                                  Month.                                                                                  300                            3                    15/60                225
                                                                                               Ages and Stages Questionnaire: 12, 18, 24                                                  300                            3                     5/60                 75
                                                                                                  Month.
                                                                                               Center for Epidemiologic Studies Depres-
                                                                                                  sion—10.
                                                  Male partners ........................       Male partner eligibility questionnaire ...........                                       2,500                             1                    5/60                208
                                                                                               Male enrollment questionnaire .....................                                        625                             1                   25/60                260
                                                                                               Adult symptoms questionnaire .....................                                         625                             7                   10/60                729

                                                       Total ...............................   .......................................................................   ........................   ........................   ........................         20,840



                                                  Leroy A. Richardson,                                                       Written comments and suggestions                                           send an email to omb@cdc.gov. Written
                                                  Chief, Information Collection Review Office,                            from the public and affected agencies                                         comments and/or suggestions regarding
                                                  Office of Scientific Integrity, Office of the                           concerning the proposed collection of                                         the items contained in this notice
                                                  Associate Director for Science, Office of the                           information are encouraged. Your                                              should be directed to the Attention:
                                                  Director, Centers for Disease Control and                               comments should address any of the                                            CDC Desk Officer, Office of Management
                                                  Prevention.                                                             following: (a) Evaluate whether the                                           and Budget, Washington, DC 20503 or
                                                  [FR Doc. 2017–18405 Filed 8–29–17; 8:45 am]                             proposed collection of information is                                         by fax to (202) 395–5806. Written
                                                  BILLING CODE 4163–18–P                                                  necessary for the proper performance of                                       comments should be received within 30
                                                                                                                          the functions of the agency, including                                        days of this notice.
                                                                                                                          whether the information will have
                                                  DEPARTMENT OF HEALTH AND                                                practical utility; (b) Evaluate the                                           Proposed Project
                                                  HUMAN SERVICES                                                          accuracy of the agencies estimate of the                                        National Disease Surveillance
                                                                                                                          burden of the proposed collection of                                          Program II. Disease Summaries (OMB
                                                  Centers for Disease Control and                                         information, including the validity of                                        Control Number 0920–0004, Expires
                                                  Prevention                                                              the methodology and assumptions used;                                         10/31/2017)—Revision—National
                                                                                                                          (c) Enhance the quality, utility, and                                         Center for Immunization and
                                                  [30Day–17–0004]                                                         clarity of the information to be                                              Respiratory Diseases, Centers for
                                                                                                                          collected; (d) Minimize the burden of                                         Disease Control and Prevention (CDC).
                                                  Agency Forms Undergoing Paperwork                                       the collection of information on those
                                                                                                                                                                                                        Background and Brief Description
                                                  Reduction Act Review                                                    who are to respond, including through
                                                                                                                          the use of appropriate automated,                                               CDC requests a three-year approval for
                                                    The Centers for Disease Control and                                   electronic, mechanical, or other                                              the proposed revision of the ‘‘National
                                                  Prevention (CDC) has submitted the                                      technological collection techniques or                                        Disease Surveillance Program II. Disease
                                                  following information collection request                                other forms of information technology,                                        Summaries’’ information collection
mstockstill on DSK30JT082PROD with NOTICES




                                                  to the Office of Management and Budget                                  e.g., permitting electronic submission of                                     project.
                                                  (OMB) for review and approval in                                        responses; and (e) Assess information                                           As with the previous approval, these
                                                  accordance with the Paperwork                                           collection costs.                                                             data are essential for measuring trends
                                                  Reduction Act of 1995. The notice for                                      To request additional information on                                       in diseases, evaluating the effectiveness
                                                  the proposed information collection is                                  the proposed project or to obtain a copy                                      of current preventive strategies, and
                                                  published to obtain comments from the                                   of the information collection plan and                                        determining the need to modify current
                                                  public and affected agencies.                                           instruments, call (404) 639–7570 or                                           preventive measures.


                                             VerDate Sep<11>2014      17:40 Aug 29, 2017        Jkt 241001        PO 00000        Frm 00061        Fmt 4703        Sfmt 4703      E:\FR\FM\30AUN1.SGM               30AUN1


                                                  41268                            Federal Register / Vol. 82, No. 167 / Wednesday, August 30, 2017 / Notices

                                                    Diseases included in this surveillance                      Respiratory & Enteric Virus Surveillance                     The frequency of response for each
                                                  program are Influenza Virus,                                  System (NREVSS) Laboratory                                 form will depend on the disease and
                                                  Caliciviruses, Respiratory and Enteric                        Assessment (CDC 55.83). CDC also                           surveillance need. This represents a
                                                  Viruses, Foodborne Outbreaks,                                 requests the use of a new form, Suspect                    7,116 burden hour reduction since last
                                                  Waterborne Outbreaks and                                      Respiratory Virus Patient Form, to assist                  approval. This reduction in burden
                                                  Enteroviruses.                                                health departments and clinical sites                      hours is attributed primarily to the
                                                    Proposed revisions include form                             when they submit specimens to the CDC                      discontinuation of previously approved
                                                  consolidation, minor revised language                         lab for viral pathogen identification. The                 forms and formatting changes to existing
                                                  and rewording to improve clarity and                          data will enable rapid detection and                       forms. The total time burden estimate
                                                  readability of the data collection forms                      characterization of outbreaks of known                     for all collection instruments in this
                                                  and the discontinuation of multiple                           pathogens, as well as potential newly                      revision request is 24,805.
                                                  previously approved influenza                                 emerging viral pathogens.                                    There are no costs to the respondents
                                                  collection instruments, and the National                                                                                 other than their time.
                                                                                                               ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                             Number of     Avg. burden
                                                                                                                                                                           Number of
                                                    Type of respondent                                               Form name                                                             responses per   per response
                                                                                                                                                                          respondents        respondent     (in hours)

                                                  Epidemiologist ............      NORS Foodborne Disease Transmission_Person to Person Disease                                     54                37          20/60
                                                                                      Transmission_Animal Contact_Environmental Contamination_Un-
                                                                                      known Transmission Mode_52.13.
                                                  Epidemiologist ............      WHO COLLABORATING CENTER FOR INFLUENZA Influenza                                                 53                52          10/60
                                                                                      Virus Surveillance.
                                                  Epidemiologist ............      U.S. WHO Collaborating Laboratories Influenza Testing Methods                                   113                 1          10/60
                                                                                      Assessment.
                                                  Epidemiologist ............      US Outpatient Influenza-like Illness Surveillance Network (ILINet)                             1,800               52          10/60
                                                                                      Weekly_CDC 55.20.
                                                  Epidemiologist ............      US Outpatient Influenza-like Illness Surveillance Network (ILINet)                             1800                 1           5/60
                                                                                      Workfolder 55.20E.
                                                  Epidemiologist    ............   Influenza-Associated Pediatric Mortality Case Report Form ..............                         57                 2          30/60
                                                  Epidemiologist    ............   Human Infection with Novel Influenza A Virus Case Report Form ....                               57                 2          30/60
                                                  Epidemiologist    ............   Human Infection with Novel Influenza A Virus Severe Outcomes .....                               57                 1          90/60
                                                  Epidemiologist    ............   Novel Influenza A Virus Case Screening Form ..................................                   57                 1          15/60
                                                  Epidemiologist    ............   Antiviral Resistant Influenza Infection Case Report Form ..................                      57                 3          30/60
                                                  Epidemiologist    ............   National Respiratory & Enteric Virus Surveillance System                                        550                52          15/60
                                                                                      (NREVSS) (55.83A, B, D) (electronic).
                                                  Epidemiologist ............      National Enterovirus Surveillance Report: (CDC 55.9) (electronic) ....                           20                12          15/60
                                                  Epidemiologist ............      National Adenovirus Type Reporting System (NATRS) .....................                          13                 4          15/60
                                                  Epidemiologist ............      Middle East Respiratory Syndrome (MERS) Patient Under Investiga-                                 57                 3          25/60
                                                                                      tion (PUI) Short Form.
                                                  Epidemiologist ............      Viral Gastroenteritis Outbreak Submission Form ................................                  20                 5           5/60
                                                  Epidemiologist ............      NORS Waterborne Disease Transmission Form_52.12 .....................                            59                 1          20/60
                                                  Epidemiologist ............      Influenza Virus (Electronic, Year Round), PHLIP_HL7 messaging                                    57                52           5/60
                                                                                      Data Elements.
                                                  Epidemiologist ............      Influenza virus (electronic, year round) (PHIN–MS) ...........................                    3                52           5/60
                                                  Epidemiologist ............      Suspect Respiratory Virus Patient Form .............................................             10                 5          30/60



                                                  Leroy A. Richardson,                                          DEPARTMENT OF HEALTH AND                                   publish notice in the Federal Register
                                                  Chief, Information Collection Review Office,                  HUMAN SERVICES                                             concerning each proposed collection of
                                                  Office of Scientific Integrity, Office of the                                                                            information, including each proposed
                                                  Associate Director for Science, Office of the                 Centers for Medicare & Medicaid                            extension or reinstatement of an existing
                                                  Director, Centers for Disease Control and                     Services                                                   collection of information, and to allow
                                                  Prevention.                                                                                                              a second opportunity for public
                                                                                                                [Document Identifier CMS–10239]
                                                  [FR Doc. 2017–18407 Filed 8–29–17; 8:45 am]                                                                              comment on the notice. Interested
                                                  BILLING CODE 4163–18–P                                        Agency Information Collection                              persons are invited to send comments
                                                                                                                Activities: Submission for OMB                             regarding the burden estimate or any
                                                                                                                Review; Comment Request                                    other aspect of this collection of
                                                                                                                AGENCY: Centers for Medicare &                             information, including the necessity and
                                                                                                                Medicaid Services, HHS.                                    utility of the proposed information
                                                                                                                                                                           collection for the proper performance of
                                                                                                                ACTION: Notice.
                                                                                                                                                                           the agency’s functions, the accuracy of
mstockstill on DSK30JT082PROD with NOTICES




                                                                                                                SUMMARY:  The Centers for Medicare &                       the estimated burden, ways to enhance
                                                                                                                Medicaid Services (CMS) is announcing                      the quality, utility, and clarity of the
                                                                                                                an opportunity for the public to                           information to be collected; and the use
                                                                                                                comment on CMS’ intention to collect                       of automated collection techniques or
                                                                                                                information from the public. Under the                     other forms of information technology to
                                                                                                                Paperwork Reduction Act of 1995                            minimize the information collection
                                                                                                                (PRA), federal agencies are required to                    burden.


                                             VerDate Sep<11>2014    17:40 Aug 29, 2017      Jkt 241001    PO 00000    Frm 00062    Fmt 4703    Sfmt 4703    E:\FR\FM\30AUN1.SGM   30AUN1



Document Created: 2017-08-30 04:08:30
Document Modified: 2017-08-30 04:08:30
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation82 FR 41267 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR